The company said its board determined it needs to review Kawas’s conduct during doctoral research at Washington State University.
source https://www.seattletimes.com/business/athira-pharma-places-ceo-on-leave/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_technology
No comments:
Post a Comment